Top Story

NCI awards $8.3 million for research into prevention of HPV-related cancers

February 16, 2020

Medical oncologist to receive award for cancer drug development

February 15, 2020
European Society for Medical Oncology will present Lillian L. Siu, MD, FRCPC, with the TAT 2020 Honorary Award. The award recognizes Siu’s contributions to the…
In the Journals

HSD3B1 genotype linked to worse outcomes in low-volume metastatic prostate cancer

February 14, 2020
The adrenal-permissive HSD3B1 genotype appeared associated with earlier castration resistance and shorter OS among men with low-volume metastatic prostate cancer…
In the Journals

Study evaluates malignancy prediction models for pulmonary nodules

February 14, 2020
In a study of models for predicting malignancy in pulmonary nodules, researchers found that those developed using data from the Pan-Canadian Early Detection of Lung…
FDA News

FDA grants priority review to Tazverik for relapsed, refractory follicular lymphoma

February 14, 2020
The FDA granted priority review to tazemetostat for the treatment of patients with relapsed or refractory follicular lymphoma. Tazemetostat (Tazverik, Epizyme) — a…
More Headlines »
Current Issues
View the Current Issue
HemOnc Today Cell Therapy Next